Press review: Israel in Syrian de-escalation plan and Brexit at dead-endPress Review July 21, 13:00
Russia to develop artillery reconnaissance drone — sourceMilitary & Defense July 21, 12:36
Siemens has no plans to withdraw from Russian market — company’s representativeBusiness & Economy July 21, 11:51
Russia to supply another batch of transport helicopters to China in 2018Business & Economy July 21, 11:47
Siemens reports 4 turbines it produced ‘illicitly’ sent to Crimea 'contrary' to contractsBusiness & Economy July 21, 10:11
Records file on Gagarin flight fetches nearly $50,000 at Sotheby’sSociety & Culture July 21, 10:00
Russian-Chinese naval exercises kick off in Baltic SeaMilitary & Defense July 21, 9:47
IMF Executive Board decides on $1.8 billion conditional loan for GreeceBusiness & Economy July 21, 3:34
Turkey’s western coast rocked by 6.7 magnitude quakeWorld July 21, 2:58
ST. PETERSBURG, December 29. /TASS/. A group of scientists at the St. Petersburg-based Research Institute of Influenza have developed a vaccine against the deadly Ebola virus and its trials are due to complete in Africa in February, the director of the institute said on Monday.
“The candidate vaccine against Ebola created by a group of young scientists of our institute is undergoing tests for genetic stability,” Oleg Kiselev said, adding that the vaccine will be called “candidate” until its industrial production begins.
The vaccine has been already sent to the Virology Center of the Ministry of Defense and will be first tested on animals. The clinical tests involving volunteers will be conducted in Africa.
All the stages of trials are due to wrap up in February, Kiselev said.
The latest figures by the World Health Organization (WHO) show that the death toll from the current Ebola outbreak has reached 7,693 and as many as 19,695 have been infected. Most deaths were reported in the hardest-hit West African countries — Liberia, Sierra Leone and Guinea.